These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33001302)

  • 1. ASO Author Reflections: ypTNM Stage Grouping in the 8th Edition of the AJCC Cancer Staging Manual Refines the Prognostic Prediction for Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy.
    Sudo N; Ichikawa H; Muneoka Y; Hanyu T; Kano Y; Ishikawa T; Hirose Y; Miura K; Shimada Y; Nagahashi M; Sakata J; Kobayashi T; Bamba T; Nakagawa S; Kosugi SI; Wakai T
    Ann Surg Oncol; 2021 Feb; 28(2):661-662. PubMed ID: 33001302
    [No Abstract]   [Full Text] [Related]  

  • 2. Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy: Unification of the AJCC staging system and the Japanese classification.
    Oshikiri T; Goto H; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Kakeji Y
    Eur J Surg Oncol; 2022 Aug; 48(8):1760-1767. PubMed ID: 35094909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Utility of ypTNM Stage Grouping in the 8th Edition of the American Joint Committee on Cancer TNM Staging System for Esophageal Squamous Cell Carcinoma.
    Sudo N; Ichikawa H; Muneoka Y; Hanyu T; Kano Y; Ishikawa T; Hirose Y; Miura K; Shimada Y; Nagahashi M; Sakata J; Kobayashi T; Bamba T; Nakagawa S; Kosugi SI; Wakai T
    Ann Surg Oncol; 2021 Feb; 28(2):650-660. PubMed ID: 33025354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Rice TW; Ishwaran H; Kelsen DP; Hofstetter WL; Apperson-Hansen C; Blackstone EH;
    Dis Esophagus; 2016 Nov; 29(8):906-912. PubMed ID: 27905170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell Carcinoma.
    Matsuda S; Kawakubo H; Okamura A; Takahashi K; Toihata T; Takemura R; Mayanagi S; Takeuchi H; Watanabe M; Kitagawa Y
    Ann Surg Oncol; 2021 Dec; 28(13):8448-8449. PubMed ID: 34143335
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel tumor staging system incorporating cN status for stratifying early stage esophageal squamous cell carcinoma patients after trimodal therapy.
    Li X; Luan S; Zhang C; Kong W; Xiao X; Zhang H; Zhou J; Yang Y; Xu Y; Qiang Y; Fang P; Shen Y; Yuan Y
    Eur J Surg Oncol; 2024 Jan; 50(1):107264. PubMed ID: 37977046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi-Institutional Study.
    Zhong Q; Chen QY; Parisi A; Ma YB; Lin GT; Desiderio J; Yan S; Xie JW; Wang JB; Hou JF; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Liu ZY; Que SJ; Li P; Zheng CH; Huang CM
    Oncologist; 2021 Jan; 26(1):e99-e110. PubMed ID: 32864840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy.
    Deng W; Chen J; Xiao Z
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):802-803. PubMed ID: 31654164
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment.
    Sisic L; Blank S; Nienhüser H; Dorr S; Haag GM; Jäger D; Bruckner T; Müller-Stich BP; Ott K; Büchler MW; Ulrich A; Schmidt T
    Eur J Surg Oncol; 2018 Oct; 44(10):1646-1656. PubMed ID: 30082176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prognostic Value of the AJCC 8th Edition Staging System for Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
    Kantor O; Bao J; Jaskowiak N; Yao K; Tseng J
    Ann Surg Oncol; 2020 Feb; 27(2):352-358. PubMed ID: 31376037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do tumor location and grade affect survival in pT2N0M0 esophageal squamous cell carcinoma?
    Situ D; Wang J; Lin P; Long H; Zhang L; Rong T; Ma G
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):45-51. PubMed ID: 23490249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASO Author Reflections: Prediction of the Therapeutic Efficacy in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
    Okamura A; Matsuda S; Kawakubo H; Mine S; Takeuchi H; Kitagawa Y; Watanabe M
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):795-796. PubMed ID: 32591950
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the prognostic value of the 6th and 7th editions of the Union for International Cancer Control TNM staging system in patients with lower esophageal cancer undergoing neoadjuvant chemotherapy followed by surgery.
    Mehta SP; Jose P; Mirza A; Pritchard SA; Hayden JD; Grabsch HI
    Dis Esophagus; 2013; 26(2):182-8. PubMed ID: 22591020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the eighth edition TNM staging system for esophageal cancer among patients receiving neoadjuvant therapy: A SEER study.
    Yuan Y; Ma G; Hu X; Huang Q
    Cancer Med; 2020 Jul; 9(13):4648-4655. PubMed ID: 32391623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma.
    Okamura A; Watanabe M; Okui J; Matsuda S; Takemura R; Kawakubo H; Takeuchi H; Muto M; Kakeji Y; Kitagawa Y; Doki Y
    Ann Surg Oncol; 2023 Apr; 30(4):2186-2187. PubMed ID: 36538253
    [No Abstract]   [Full Text] [Related]  

  • 17. Proposed revision of N categories to the 8th edition of the AJCC-TNM staging system for non-surgical esophageal squamous cell cancer.
    Hu K; Kang N; Liu Y; Guo D; Jing W; Lu J; Tan T; Lv C; Deng Y; Long J; Wang R; Yu J
    Cancer Sci; 2019 Feb; 110(2):717-725. PubMed ID: 30467921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data.
    Rice TW; Lerut TE; Orringer MB; Chen LQ; Hofstetter WL; Smithers BM; Rusch VW; van Lanschot J; Chen KN; Davies AR; D'Journo XB; Kesler KA; Luketich JD; Ferguson MK; Räsänen JV; van Hillegersberg R; Fang W; Durand L; Allum WH; Cecconello I; Cerfolio RJ; Pera M; Griffin SM; Burger R; Liu JF; Allen MS; Law S; Watson TJ; Darling GE; Scott WJ; Duranceau A; Denlinger CE; Schipper PH; Ishwaran H; Apperson-Hansen C; DiPaola LM; Semple ME; Blackstone EH
    Dis Esophagus; 2016 Oct; 29(7):715-723. PubMed ID: 27731548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASO Author Reflections: Association Between Preoperative Coagulation Status and Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma After Neoadjuvant Treatment.
    Sugiyama F; Kanda M; Kodera Y
    Ann Surg Oncol; 2024 May; 31(5):3473-3474. PubMed ID: 38261127
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Decrease of Albumin and Derived Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy Reflect the Worse Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
    Abe T; Oshikiri T; Goto H; Kato T; Horikawa M; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
    Ann Surg Oncol; 2022 Oct; 29(11):6867-6868. PubMed ID: 35616746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.